Preference for Distinct Functional Conformations of the Dopamine Transporter Alters the Relationship Between Subjective Effects of Cocaine and Stimulation of Mesolimbic Dopamine

Overview

Journal Biol Psychiatry

Publisher Elsevier

Specialty Psychiatry

Date 2014 May 24

PMID 24853388

Citations 34

Authors

Stephen J Kohut

Takato Hiranita

Soo-Kyung Hong

Aaron L Ebbs

Valeria Tronci

Jennifer Green

Linda Garces-Ramirez

Lauren E Chun

Maddalena Mereu

Amy H Newman

Jonathan L Katz

Gianluigi Tanda

Affiliations

Soon will be listed here.

Abstract

Background: Subjective effects of cocaine are mediated primarily by dopamine (DA) transporter (DAT) blockade. The present study assessed the hypothesis that different DAT conformational equilibria regulate differences in cocaine-like subjective effects and extracellular DA induced by diverse DA-uptake inhibitors (DUIs).

Methods: The relationship between cocaine-like subjective effects and stimulation of mesolimbic DA levels by standard DUIs (cocaine, methylphenidate, WIN35,428) and atypical DUIs (benztropine analogs: AHN1-055, AHN2-005, JHW007) was investigated using cocaine discrimination and DA microdialysis procedures in rats.

Results: All drugs stimulated DA levels with different maxima and time courses. Standard DUIs, which preferentially bind outward-facing DAT conformations, fully substituted for cocaine, consistently producing cocaine-like subjective effects at DA levels of 100-125% over basal values, regardless of dose or pretreatment time. The atypical DUIs, with DAT binding minimally affected by DAT conformation, produced inconsistent cocaine-like subjective effects. Full effects were obtained, if at all, only at a few doses and pretreatment times and at DA levels 600-700% greater than basal values. Importantly, the linear, time-independent, relationship between cocaine-like subjective effects and DA stimulation obtained with standard DUIs was not obtained with the atypical DUIs.

Conclusions: These results suggest a time-related desensitization process underlying the reduced cocaine subjective effects of atypical DUIs that may be differentially induced by the binding modalities identified using molecular approaches. Since the DAT is the target of several drugs for treating neuropsychiatric disorders, such as attention-deficit/hyperactivity disorder, these results help to identify safe and effective medications with minimal cocaine-like subjective effects that contribute to abuse liability.

Citing Articles

Gabapentinoids Increase the Potency of Fentanyl and Heroin and Decrease the Potency of Naloxone to Antagonize Fentanyl and Heroin in Rats Discriminating Fentanyl.

Hiranita T, Flynn S, Grisham A, Mijares A, Murphy E, France C J Pharmacol Exp Ther. 2024; 391(2):317-334.

PMID: 39179416 PMC: 11493450. DOI: 10.1124/jpet.124.002323.

Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats.

Hersey M, Mereu M, Jones C, Bartole M, Chen A, Cao J Eur J Neurosci. 2024; 59(10):2436-2449.

PMID: 38444104 PMC: 11108740. DOI: 10.1111/ejn.16293.

Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.

Ecevitoglu A, Meka N, Rotolo R, Edelstein G, Srinath S, Beard K Neuropsychopharmacology. 2024; 49(8):1309-1317.

PMID: 38429498 PMC: 11224370. DOI: 10.1038/s41386-024-01826-1.

Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release.

Keighron J, Bonaventura J, Li Y, Yang J, DeMarco E, Hersey M Transl Psychiatry. 2023; 13(1):202.

PMID: 37311803 PMC: 10264427. DOI: 10.1038/s41398-023-02493-4.

Effects of isoflurane anesthesia on addictive behaviors in rats.

Yoon S, Lee B, Lee S, Choi S, Jeong S, Kim S Psychopharmacology (Berl). 2022; 239(11):3621-3632.

PMID: 36109391 DOI: 10.1007/s00213-022-06236-z.

References

Tanda G, Li S, Mereu M, Thomas A, Ebbs A, Chun L . Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change. Psychopharmacology (Berl). 2013; 229(2):307-21. PMC: 3758386. DOI: 10.1007/s00213-013-3109-6. View

Baker L, Riddle E, Saunders R, Appel J . The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol. 1993; 4(1):69-79. View

Hiranita T, Soto P, Kohut S, Kopajtic T, Cao J, Newman A . Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. J Pharmacol Exp Ther. 2011; 339(2):662-77. PMC: 3199989. DOI: 10.1124/jpet.111.185025. View

Tanda G, Ebbs A, Newman A, Katz J . Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther. 2005; 313(2):613-20. DOI: 10.1124/jpet.104.080465. View

Garces-Ramirez L, Green J, Hiranita T, Kopajtic T, Mereu M, Thomas A . Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry. 2010; 69(3):208-17. PMC: 3015019. DOI: 10.1016/j.biopsych.2010.07.026. View

Pontieri F, Tanda G, Di Chiara G . Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A. 1995; 92(26):12304-8. PMC: 40345. DOI: 10.1073/pnas.92.26.12304. View

Volkow N, Wang G, FISCHMAN M, Foltin R, Fowler J, Abumrad N . Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 1997; 386(6627):827-30. DOI: 10.1038/386827a0. View

Katz N, Guiard B, El Mansari M, Blier P . Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons. J Psychopharmacol. 2009; 24(8):1223-35. DOI: 10.1177/0269881109348178. View

Campbell V, Kopajtic T, Newman A, Katz J . Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs. J Pharmacol Exp Ther. 2005; 315(2):631-40. DOI: 10.1124/jpet.105.090829. View

10.

Desai R, Kopajtic T, French D, Newman A, Katz J . Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs. J Pharmacol Exp Ther. 2005; 315(1):397-404. DOI: 10.1124/jpet.105.091231. View

11.

Katz J, Kopajtic T, Agoston G, Newman A . Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther. 2004; 309(2):650-60. DOI: 10.1124/jpet.103.060525. View

12.

Katz J, Izenwasser S, Terry P . Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology (Berl). 2000; 148(1):90-8. DOI: 10.1007/s002130050029. View

13.

Beuming T, Kniazeff J, Bergmann M, Shi L, Gracia L, Raniszewska K . The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci. 2008; 11(7):780-9. PMC: 2692229. DOI: 10.1038/nn.2146. View

14.

Li S, Kopajtic T, OCallaghan M, Agoston G, Cao J, Newman A . N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. J Pharmacol Exp Ther. 2010; 336(2):575-85. PMC: 3033723. DOI: 10.1124/jpet.110.173260. View

15.

Tanda G, Ebbs A, Kopajtic T, Elias L, Campbell B, Newman A . Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther. 2007; 321(1):334-44. DOI: 10.1124/jpet.106.118067. View

16.

Raje S, Cao J, Newman A, Gao H, Eddington N . Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther. 2003; 307(2):801-8. DOI: 10.1124/jpet.103.053504. View

17.

Raje S, Cornish J, Newman A, Cao J, Katz J, Eddington N . Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Pharm Res. 2005; 22(4):603-12. DOI: 10.1007/s11095-005-2488-8. View

18.

Callahan P, De La Garza 2nd R, Cunningham K . Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav. 1997; 57(3):601-7. DOI: 10.1016/s0091-3057(96)00434-0. View

19.

Dworkin S, Smith J . Neurobehavioral pharmacology of cocaine. NIDA Res Monogr. 1988; 88:185-98. View

20.

Czoty P, Makriyannis A, Bergman J . Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology (Berl). 2004; 175(2):170-8. DOI: 10.1007/s00213-004-1798-6. View